资讯

Mesenchymal stem cells can self-renew by dividing and can differentiate into multiple tissues including bone, cartilage, muscle and fat cells, and connective tissue. Latest Research and Reviews ...
This valuable study presents a novel approach to enhance the therapeutic potential of mesenchymal stromal cells (MSCs) by genetically modifying their glycogen synthesis pathway, resulting in increased ...
Mesoblast Limited (NASDAQ:MESO) is one of the 7 Best ASX Stocks to Buy Now. The company announced that it received 7 years of ...
INmune Bio Inc. (NASDAQ: INMB) (the 'Company”), a clinical-stage inflammation and immunology company, today announced that it ...
Barcelona’s blood and tissue bank says it has developed a new system for the large-scale production of mesenchymal stromal cells.
日本再生医疗学会指出,改变术语的原因在于,“间叶系干细胞”这一名称容易引发误解,让公众误认为这些细胞能够像传统干细胞一样,具有强大的分化和自我复制能力。实际上,许多临床应用中使用的脂肪来源细胞,功能是有限的,仅能支持局部的组织修复或再生,而不能像骨髓或脐带来源的干细胞那样,拥有广泛的分化潜力。因此,学会决定根据国际标准,采用“间叶系间质细胞”这一名称,以确保术语的准确性。
In the Phase 2 MINDFuL trial of XProTM in patients with early Alzheimer's Disease (AD) with biomarkers of inflammation, the modified intent-to-treat ...
The complex tumor microenvironment (TME) in osteosarcoma is emerging as a critical factor in disease progression and ...
NeuroScientific Biopharmaceuticals has acquired unlisted Perth-based Isopogen for $5.1 million, gaining control of the ...
In the Phase 2 MINDFuL trial of XPro™ in patients with early Alzheimer’s Disease (AD) with biomarkers of inflammation, the modified intent-to-treat (mITT) ...